SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-23-083070
Filing Date
2023-07-21
Accepted
2023-07-21 16:31:10
Documents
2
Group Members
FAIRMOUNT HEALTHCARE CO-INVEST II LPFAIRMOUNT HEALTHCARE FUND II LPFAIRMOUNT HEALTHCARE FUND LPPETER HARWINTOMAS KISELAK

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2321824d1_sc13d.htm SC 13D 134617
2 EXHIBIT 99.1 tm2321824d1_ex99-1.htm EX-99.1 10798
  Complete submission text file 0001104659-23-083070.txt   147304
Mailing Address 200 BARR HARBOR DRIVE SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE SUITE 400 WEST CONSHOHOCKEN PA 19428 267-262-5300
Fairmount Funds Management LLC (Filed by) CIK: 0001802528 (see all company filings)

IRS No.: 364841215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Subject) CIK: 0001974640 (see all company filings)

IRS No.: 880588063 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-94122 | Film No.: 231102878
SIC: 2836 Biological Products, (No Diagnostic Substances)